GRIFOLS | GRF - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alcon AG USD 1.58B 80M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
Amadeus IT EUR 975.6M 7.4M 2025-12
Amarin USD 131.06M 3.6M 2026-03
argenx SE USD 4.3B 808.71M 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
Cie Automotive EUR 486.62M 9.22M 2024-12
Demant DKK 1.33B 188M 2025-12
Ence Energia y Celulosa EUR 195M 54.6M 2026-03
Essilor EUR 3.54B 758M 2025-12
Ferrovial EUR 4.24B 1.41B 2025-12
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 801M 242.31M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
Inditex EUR 5.28B 675M 2025-12
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Merck EUR 2.33B 77M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Philips EUR 2.79B 882M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12
Viscofan EUR 62.79M 16.26M 2025-12